So much to unpack here. Have only briefly read this. It’s going to take some time to dig into.
It seems like a poorly written paper with very odd inclusion of information about the pressures they were under. I can imagine it surviving peer review.
I hope journalists are now enlisting the expertise of unconnected Statisticians and
Psychologists for comment.
I would also like to hear from a clinical trials expert. This should be a registered clinical trial. Maybe it’s published in this paper but should be elsewhere.. where is the trial protocol?
It seems to me they might be in breach of their own trial and trial regulations, if after one year some of the criteria were worse (suicide scores). Is this correct? I haven’t read the paper through yet. I’ve just seen some of you comment about it on here.
In any other trial, if the experimental drug was shown to lead to a worsening of outcomes at any point, the trial should immediately be halted and reported to the regulators.
Critical question: did they breach their own trial protocol guidelines on safety and report increased suicide measures to the regulator as a Serious Adverse Event ??